The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases
Open accessAbstract
Fatty acid-binding proteins (FABPs), a family of lipid chaperones, contribute to systemic metabolic regulation via several lipid signaling pathways. Fatty acid-binding protein 4 (FABP4), known as adipocyte FABP (A-FABP) or aP2, is mainly expressed in adipocytes and macrophages and plays important roles in the development of insulin resistance and atherosclerosis in relation to metabolically driven low-grade and chronic inflammation, referred to as 'metaflammation'. FABP4 is secreted from adipocytes in a non-classical pathway associated with lipolysis and acts as an adipokine for the development of insulin resistance and atherosclerosis. Circulating FABP4 levels are associated with several aspects of metabolic syndrome and cardiovascular disease. Ectopic expression and function of FABP4 in cells and tissues are also related to the pathogenesis of several diseases. Pharmacological modification of FABP4 function by specific inhibitors, neutralizing antibodies or antagonists of unidentified receptors would be novel therapeutic strategies for several diseases, including obesity, diabetes mellitus, atherosclerosis and cardiovascular disease. Significant roles of FABP4 as a lipid chaperone in physiological and pathophysiological conditions and the possibility of FABP4 being a therapeutic target for metabolic and cardiovascular diseases are discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Furuhashi, M., & Hotamisligil, G. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2589 · Cited by 1,785
Self-citationIdentification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism
Cao, H., Gerhold, K., Mayers, J. R., Wiest, M. M., Watkins, S. M., & Hotamisligil, G. S. (2008) · Cell · doi:10.1016/j.cell.2008.07.048 · Cited by 1,139
Hotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism
Chmurzyńska, A. (2006) · Journal of Applied Genetics · doi:10.1007/bf03194597 · Cited by 744
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
Furuhashi, M., Tuncman, G., Görgün, C. Z., Makowski, L., Atsumi, G., Vaillancourt, E., Kono, K., Babaev, V. R., Fazio, S., Linton, M. F., et al. (2007) · Nature · doi:10.1038/nature05844 · Cited by 718
Self-citationMetabolic functions of FABPs—mechanisms and therapeutic implications
Hotamisligil, G. S., & Bernlohr, D. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.122 · Cited by 712
Mechanisms of regulated unconventional protein secretion
Nickel, W., & Rabouille, C. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2617 · Cited by 702
Makowski, L., Boord, J. B., Maeda, K., Babaev, V. R., Uysal, K. T., Morgan, M. A., Parker, R. A., Suttles, J., Fazio, S., Hotamisligil, G. S., et al. (2001) · Nature Medicine · doi:10.1038/89076 · Cited by 686
Xu, A., Wang, Y., Xu, J. Y., Stejskal, D., Tam, S., Zhang, J., Wat, N. M., Wong, W. K., & Lam, K. S. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.062463 · Cited by 602
Common DNA binding site for Fos protein complexesand transcription factor AP-1
Rauscher, F. J., Sambucetti, L. C., Curran, T., Distel, R. J., & Spiegelman, B. M. (1988) · Cell · doi:10.1016/s0092-8674(88)80039-4 · Cited by 599
Christy, R. J., Yang, V. W., Ntambi, J. M., Geiman, D. E., Landschulz, W. H., Friedman, A. D., Nakabeppu, Y., Kelly, T. J., & Lane, M. D. (1989) · Genes & Development · doi:10.1101/gad.3.9.1323 · Cited by 568
Furuhashi, M., Saitoh, S., Shimamoto, K., & Miura, T. (2014) · Clinical Medicine Insights: Cardiology · doi:10.4137/cmc.s17067 · Cited by 489
Self-citationErbay, E., Babaev, V. R., Mayers, J. R., Makowski, L., Charles, K. N., Snitow, M. E., Fazio, S., Wiest, M. M., Watkins, S. M., Linton, M. F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2067 · Cited by 485
Maeda, K., Cao, H., Kono, K., Gorgun, C. Z., Furuhashi, M., Uysal, K. T., Cao, Q., Atsumi, G., Malone, H., Krishnan, B., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.008 · Cited by 477
Self-citationMakowski, L., Brittingham, K. C., Reynolds, J. M., Suttles, J., & Hotamisligil, G. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413788200 · Cited by 410
Mozaffarian, D., Cao, H., King, I. B., Lemaitre, R. N., Song, X., Siscovick, D. S., & Hotamisligil, G. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-12-201012210-00005 · Cited by 363
Xu, A., Tso, A. W. K., Cheung, B. M. Y., Wang, Y., Wat, N. M. S., Fong, C. H. Y., Yeung, D. C. Y., Janus, E. D., Sham, P. C., & Lam, K. S. L. (2007) · Circulation · doi:10.1161/circulationaha.106.647503 · Cited by 360
Furuhashi, M., Fucho, R., Görgün, C. Z., Tuncman, G., Cao, H., & Hotamisligil, G. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34750 · Cited by 332
Self-citationFABP4 Attenuates PPARγ and Adipogenesis and Is Inversely Correlated With PPARγ in Adipose Tissues
Garin-Shkolnik, T., Rudich, A., Hotamisligil, G. S., & Rubinstein, M. (2014) · Diabetes · doi:10.2337/db13-0436 · Cited by 332
Elmasri, H., Karaaslan, C., Teper, Y., Ghelfi, E., Weng, M., Ince, T. A., Kozakewich, H., Bischoff, J., & Cataltepe, S. (2009) · The FASEB Journal · doi:10.1096/fj.09-134882 · Cited by 328
Improved Glucose and Lipid Metabolism in Genetically Obese Mice Lacking aP2
Uysal, K. T., Scheja, L., Wiesbrock, S. M., Bonner‐Weir, S., & Hotamışlıgil, G. S. (2000) · Endocrinology · doi:10.1210/en.141.9.3388 · Cited by 324
Metabolic reprogramming, caloric restriction and aging
Anderson, R. M., & Weindruch, R. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.005 · Cited by 301
Tso, A. W. K., Xu, A., Sham, P. C., Wat, N. M. S., Wang, Y., Fong, C. H. Y., Cheung, B. M. Y., Janus, E. D., & Lam, K. S. L. (2007) · Diabetes Care · doi:10.2337/dc07-0413 · Cited by 291
Tuncman, G., Erbay, E., Hom, X., De Vivo, I., Campos, H., Rimm, E. B., & Hotamisligil, G. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602178103 · Cited by 277
Adipocyte Lipid Chaperone aP2 Is a Secreted Adipokine Regulating Hepatic Glucose Production
Cao, H., Sekiya, M., Ertunc, M. E., Burak, M. F., Mayers, J. R., White, A., Inouye, K., Rickey, L. M., Ercal, B. C., Furuhashi, M., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.012 · Cited by 274
Self-citationPerivascular adipose tissue: More than just structural support
Szasz, T., & Webb, R. C. (2012) · Clinical Science · doi:10.1042/cs20110151 · Cited by 265
Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression.
Amri, E., Bertrand, B., Ailhaud, G., & Grimaldi, P. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41912-1 · Cited by 244
Role of the Fatty Acid Binding Protein mal1 in Obesity and Insulin Resistance
Maeda, K., Uysal, K. T., Makowski, L., Görgün, C. Z., Atsumi, G., Parker, R. A., Brüning, J., Hertzel, A. V., Bernlohr, D. A., & Hotamisligil, G. S. (2003) · Diabetes · doi:10.2337/diabetes.52.2.300 · Cited by 224
Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.
Scheja, L., Makowski, L., Uysal, K. T., Wiesbrock, S. M., Shimshek, D. R., Meyers, D. S., Morgan, M., Parker, R. A., & Hotamisligil, G. S. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1987 · Cited by 217
Yeung, D. C. Y., Xu, A., Cheung, C. W. S., Wat, N. M. S., Yau, M. H., Fong, C. H. Y., Chau, M. T., & Lam, K. S. L. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.146274 · Cited by 213
A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo.
Ross, S. R., Graves, R. A., Greenstein, A., Platt, K. A., Shyu, H. L., Mellovitz, B., & Spiegelman, B. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9590 · Cited by 213
FABP4 as a key determinant of metastatic potential of ovarian cancer
Gharpure, K. M., Pradeep, S., Sans, M., Rupaimoole, R., Ivan, C., Wu, S. Y., Bayraktar, E., Nagaraja, A. S., Mangala, L. S., Zhang, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04987-y · Cited by 210
Lamounier-Zepter, V., Look, C., Alvarez, J., Christ, T., Ravens, U., Schunck, W.-H., Ehrhart-Bornstein, M., Bornstein, S. R., & Morano, I. (2009) · Circulation Research · doi:10.1161/circresaha.109.200501 · Cited by 203
Fatty acid regulation of gene expression. Transcriptional and post-transcriptional mechanisms.
Distel, R. J., Robinson, G. S., & Spiegelman, B. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42645-2 · Cited by 201
Kamijo, A., Kimura, K., Sugaya, T., Yamanouchi, M., Hikawa, A., Hirano, N., Hirata, Y., Goto, A., & Omata, M. (2004) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2003.08.001 · Cited by 200
Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein
Shen, W.-J., Sridhar, K., Bernlohr, D. A., & Kraemer, F. B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5528 · Cited by 198
Boord, J. B., Maeda, K., Makowski, L., Babaev, V. R., Fazio, S., Linton, M. F., & Hotamisligil, G. S. (2004) · Circulation · doi:10.1161/01.cir.0000141735.13202.b6 · Cited by 193
Hui, X., Li, H., Zhou, Z., Lam, K. S. L., Xiao, Y., Wu, D., Ding, K., Wang, Y., Vanhoutte, P. M., & Xu, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.097907 · Cited by 189
Pelton, P. D., Zhou, L., Demarest, K. T., & Burris, T. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1071 · Cited by 186
Fu, Y., Luo, N., Lopes-Virella, M. F., & Garvey, W. T. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00305-2 · Cited by 185
Boord, J. B., Maeda, K., Makowski, L., Babaev, V. R., Fazio, S., Linton, M. F., & Hotamisligil, G. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000033090.81345.e6 · Cited by 174
Structural Basis for Activation of Fatty Acid-binding Protein 4
Gillilan, R. E., Ayers, S. D., & Noy, N. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.040 · Cited by 171
Elmasri, H., Ghelfi, E., Yu, C.-W., Traphagen, S., Cernadas, M., Cao, H., Shi, G.-P., Plutzky, J., Sahin, M., Hotamisligil, G., et al. (2012) · Angiogenesis · doi:10.1007/s10456-012-9274-0 · Cited by 167
Cabré, A., Lázaro, I., Girona, J., Manzanares, J. M., Marimón, F., Plana, N., Heras, M., & Masana, L. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.04.045 · Cited by 165
Continuous Nucleocytoplasmic Shuttling Underlies Transcriptional Activation of PPARγ by FABP4
Ayers, S. D., Nedrow, K. L., Gillilan, R. E., & Noy, N. (2007) · Biochemistry · doi:10.1021/bi700047a · Cited by 163
Berger, W. T., Ralph, B. P., Kaczocha, M., Sun, J., Balius, T. E., Rizzo, R. C., Haj-Dahmane, S., Ojima, I., & Deutsch, D. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050968 · Cited by 162
Differential Expression of Lipid Metabolism-Related Proteins in Different Breast Cancer Subtypes
Kim, S., Lee, Y., & Koo, J. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119473 · Cited by 161
Circulating Palmitoleate Strongly and Independently Predicts Insulin Sensitivity in Humans
Stefan, N., Kantartzis, K., Celebi, N., Staiger, H., Machann, J., Schick, F., Čegan, A., Elcnerova, M., Schleicher, E. D., Fritsche, A., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0544 · Cited by 159
The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation
Shum, B. O. V., Mackay, C. R., Görgün, C. Z., Frost, M. J., Kumar, R. K., Hotamisligil, G. S., & Rolph, M. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24767 · Cited by 158
Ertunc, M. E., Sikkeland, J., Fenaroli, F., Griffiths, G., Daniels, M. P., Cao, H., Saatcioglu, F., & Hotamışlıgil, G. S. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m055798 · Cited by 155
Ishimura, S., Furuhashi, M., Watanabe, Y. S., Hoshina, K., Fuseya, T., Mita, T., Okazaki, Y., Koyama, M., Tanaka, M., Akasaka, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081318 · Cited by 154
Self-citationFatty Acid Binding Protein 4 Regulates Intracellular Lipid Accumulation in Human Trophoblasts
Scifres, C., Chen, B., Nelson, D. M., & Sadovsky, Y. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2084 · Cited by 149
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)
Sulsky, R. B., Magnin, D. R., Huang, Y., Simpkins, L. M., Taunk, P. C., Patel, M. M., Zhu, Y., Stouch, T. R., Bassolino‐Klimas, D., Parker, R. A., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.044 · Cited by 149
Iso, T., Maeda, K., Hanaoka, H., Suga, T., Goto, K., Syamsunarno, M. R. A. A., Hishiki, T., Nagahata, Y., Matsui, H., Arai, M., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301588 · Cited by 148
Kazemi, M. R., McDonald, C. M., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000159163.52632.1b · Cited by 146
Guaita‐Esteruelas, S., Bosquet, A., Saavedra-García, P., Gumà, J., Girona, J., Lam, E. W. ‐., Amillano, K., Borràs, J., & Masana, L. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22485 · Cited by 141
Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages
Fu, Y., Luo, N., & Lopes-Virella, M. F. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32363-4 · Cited by 136
Wu, L. E., Samocha‐Bonet, D., Whitworth, P. T., Fazakerley, D. J., Turner, N. A., Biden, T. J., James, D. E., & Cantley, J. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.005 · Cited by 132
von Eynatten, M., Breitling, L. P., Roos, M., Baumann, M., Rothenbacher, D., & Brenner, H. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.248609 · Cited by 131
FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women
Terra, X., Quintero, Y., Auguet, T., Porras, J. A., Hernández, M., Sabench, F., Aguilar, C., Luna, A. M., Déjardin, D. D. C., & Richart, C. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1195 · Cited by 131
Lipid Chaperones and Metabolic Inflammation
Furuhashi, M., Ishimura, S., Ota, H., & Miura, T. (2011) · International Journal of Inflammation · doi:10.4061/2011/642612 · Cited by 125
Self-citationFuruhashi, M., Fuseya, T., Murata, M., Hoshina, K., Ishimura, S., Mita, T., Watanabe, Y. S., Omori, A., Matsumoto, M., Sugaya, T., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307225 · Cited by 125
Self-citationRole of the fatty acid-binding protein 4 in heart failure and cardiovascular disease
Rodríguez‐Calvo, R., Girona, J., Alegret, J. M., Bosquet, A., Ibarretxe, D., & Masana, L. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0031 · Cited by 122
Regulation of Dendritic Cell Function and T Cell Priming by the Fatty Acid-Binding Protein aP2
Rolph, M. S., Young, T. R., Shum, B. O. V., Görgün, C. Z., Schmitz‐Peiffer, C., Ramshaw, I. A., Hotamışlıgil, G. S., & Mackay, C. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7794 · Cited by 111
Çimen, İ., Kocatürk, B., Koyuncu, S., Tufanlı, Ö., Onat, U. İ., Yıldırım, A., Apaydın, O., Demirsoy, Ş., Aykut, G., Nguyen, U. T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9087 · Cited by 111
Tang, Z., Shen, Q., Xie, H., Zhou, X., Li, J., Feng, J., Liu, H., Wang, W., Zhang, S., & Ni, S. (2016) · Oncotarget · doi:10.18632/oncotarget.10086 · Cited by 110
Kletzien, R. F., Foellmi, L. A., Harris, P. K., Wyse, B. M., & Clarke, S. D. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08970-9 · Cited by 108
Chow, W. S., Tso, A. W. K., Xu, A., Yuen, M. M. A., Fong, C. H. Y., Lam, T. H., Lo, S. V., Tse, H., Woo, Y. C., Yeung, C. Y., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.004176 · Cited by 106
Effect of exercise training on A‐FABP, lipocalin‐2 and RBP4 levels in obese women
Choi, K. M., Kim, T. N., Yoo, H. J., Lee, K. W., Cho, G. J., Hwang, T. G., Baik, S. H., Choi, D. S., & Kim, S. M. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03374.x · Cited by 106
Furuhashi, M., Ishimura, S., Ota, H., Hayashi, M., Nishitani, T., Tanaka, M., Yoshida, H., Shimamoto, K., Hotamışlıgil, G. S., & Miura, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027356 · Cited by 105
Self-citationBurak, M. F., Inouye, K., White, A., Lee, A., Tuncman, G., Calay, E. S., Sekiya, M., Tirosh, A., Eguchi, K., Birrane, G., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6336 · Cited by 104
Vural, B., Atalar, F., Çiftçi, Ç., Demirkan, A., Duman, B. S., Günay, D., Akpınar, B., Sağbaş, E., Özbek, U., & Buyukdevrim, A. S. (2008) · Cardiovascular Pathology · doi:10.1016/j.carpath.2008.02.006 · Cited by 103
Unconventional secretion of FABP4 by endosomes and secretory lysosomes
Villeneuve, J., Bassaganyas, L., Lepreux, S., Chiritoiu‐Butnaru, M., Costet, P., Ripoche, J., Malhotra, V., & Schekman, R. W. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201705047 · Cited by 102
Nishino, T., & Okamoto, K. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-014-1210-x · Cited by 101
Ota, H., Furuhashi, M., Ishimura, S., Koyama, M., Okazaki, Y., Mita, T., Fuseya, T., Yamashita, T., Tanaka, M., Yoshida, H., et al. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.88 · Cited by 101
Self-citationFABP4/aP2 Regulates Macrophage Redox Signaling and Inflammasome Activation via Control of UCP2
Steen, K. A., Xu, H., & Bernlohr, D. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00282-16 · Cited by 99
Mita, T., Furuhashi, M., Hiramitsu, S., Ishii, J., Hoshina, K., Ishimura, S., Fuseya, T., Watanabe, Y. S., Tanaka, M., Ohno, K., et al. (2014) · Obesity · doi:10.1002/oby.20954 · Cited by 96
Self-citationFuruhashi, M., Matsumoto, M., Tanaka, M., Moniwa, N., Murase, T., Nakamura, T., Ohnishi, H., Saitoh, S., Shimamoto, K., & Miura, T. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0082 · Cited by 94
Self-citationCao, H., Maeda, K., Görgün, C. Z., Kim, H., Park, S., Shulman, G. I., Kim, J. K., & Hotamışlıgil, G. S. (2006) · Diabetes · doi:10.2337/db05-1496 · Cited by 92
Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes
Cabré, A., Lázaro, I., Girona, J., Manzanares, J. M., Marimón, F., Plana, N., Heras, M., & Masana, L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800102-jlr200 · Cited by 91
Fuseya, T., Furuhashi, M., Yuda, S., Muranaka, A., Kawamukai, M., Mita, T., Ishimura, S., Watanabe, Y. S., Hoshina, K., Tanaka, M., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0126-7 · Cited by 91
Self-citationIdentification and Characterization of a Small Molecule Inhibitor of Fatty Acid Binding Proteins
Hertzel, A. V., Hellberg, K., Reynolds, J. M., Kruse, A. C., Juhlmann, B. E., Smith, A. J., Sanders, M. A., Ohlendorf, D. H., Suttles, J., & Bernlohr, D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900720m · Cited by 90
Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages
Llaverı́as, G., Noé, V., Peñuelas, S., Vázquez‐Carrera, M., Sánchez, R. M., Laguna, J. C., Ciudad, C. J., & Alegret, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.021 · Cited by 90
Chiyonobu, N., Shimada, S., Akiyama, Y., Mogushi, K., Itoh, M., Akahoshi, K., Matsumura, S., Ogawa, K., Ono, H., Mitsunori, Y., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.01.012 · Cited by 86
Lee, M. Y. K., Wang, Y., & Vanhoutte, P. M. (2009) · Journal of Vascular Research · doi:10.1159/000265563 · Cited by 84
Zhong, C., Zhang, X., Ma, N., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1511 · Cited by 84
Liu, G., Ding, M., Chiuve, S. E., Rimm, E. B., Franks, P. W., Meigs, J. B., Hu, F. B., & Sun, Q. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308320 · Cited by 83
Yao, F., Li, Z., Ehara, T., Yang, L. S., Wang, D., Feng, L., Zhang, Y., Wang, K., Shi, Y., Duan, H., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.003 · Cited by 81
Ghelfi, E., Yu, D. C. W., Elmasri, H., Terwelp, M. D., Lee, C. G., Bhandari, V., COMHAIR, S. A. A., ERZURUM, S. C., Hotamışlıgil, G. S., Elias, J. A., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.12.009 · Cited by 79
Nakamura, R., Okura, T., Fujioka, Y., Sumi, K., Matsuzawa, K., Izawa, S., Ueta, E., Kato, M., Taniguchi, S., & Yamamoto, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179737 · Cited by 77
Babaev, V. R., Runner, R. P., Fan, D., Ding, L., Zhang, Y., Tao, H., Erbay, E., Görgün, C. Z., Fazio, S., Hotamışlıgil, G. S., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.225839 · Cited by 76
Fisher, R. M., Eriksson, P. O., Hoffstedt, J., Hotamışlıgil, G. S., Thörne, A., Rydén, M., Hamsten, A., & Arner, P. (2001) · Diabetologia · doi:10.1007/s001250100643 · Cited by 73
Yu, D. C. W., Liang, X., Lipsky, S., Karaaslan, Ç., Kozakewich, H. P., Hotamışlıgil, G. S., Bischoff, J. E., & Çataltepe, S. (2015) · Angiogenesis · doi:10.1007/s10456-015-9491-4 · Cited by 71
Loss of Fatty Acid Binding Protein 4/aP2 Reduces Macrophage Inflammation Through Activation of SIRT3
Xu, H., Hertzel, A. V., Steen, K. A., & Bernlohr, D. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1301 · Cited by 71
Hofer, P., Boeszoermenyi, A., Jaeger, D., Feiler, U., Arthanari, H., Mayer, N., Zehender, F., Rechberger, G. N., Oberer, M., Zimmermann, R., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628958 · Cited by 70
Karpíšek, M., Stejskal, D., Kotolová, H., Kollár, P., Janoutová, G., Ochmanová, R., Cizek, L., Horáková, D., Yahia, R. B., Lichnovská, R., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01835.x · Cited by 70
Hu, B., Guo, Y., Garbacz, W. G., Jiang, M., Xu, M., Huang, H., Tsung, A., Billiar, T. R., Ramakrishnan, S. K., Shah, Y. M., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.030 · Cited by 70
Duffy, C. M., Xu, H., Nixon, J. P., Bernlohr, D., & Butterick, T. A. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.02.004 · Cited by 70
Lee, D., Wada, K., Taniguchi, Y., Al-Shareef, H., Masuda, T., Usami, Y., Aikawa, T., Okura, M., Kamisaki, Y., & Kogo, M. (2014) · Oncology Reports · doi:10.3892/or.2014.2975 · Cited by 67
Use of Proteomics To Investigate Kidney Function Decline over 5 Years
Carlsson, A. C., Ingelsson, E., Sundström, J., Carrero, J. J., Gustafsson, S., Feldreich, T., Stenemo, M., Larsson, A. O., Lind, L., & Ärnlöv, J. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08780816 · Cited by 67
Fuseya, T., Furuhashi, M., Matsumoto, M., Watanabe, Y. S., Hoshina, K., Mita, T., Ishimura, S., Tanaka, M., & Miura, T. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006377 · Cited by 66
Self-citationGenomic Changes in Regenerated Porcine Coronary Arterial Endothelial Cells
Lee, M. Y. K., Tse, H., Siu, C., Zhu, S., Man, R. Y. K., & Vanhoutte, P. M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.141705 · Cited by 64
Song, J., Ren, P., Zhang, L., Wang, X. L., Chen, L., & Shen, Y. H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.086 · Cited by 62
Calcium-dependent release of adipocyte fatty acid binding protein from human adipocytes
Schlottmann, I., Ehrhart‐Bornstein, M., Wabitsch, M., Bornstein, S. R., & Lamounier‐Zepter, V. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.241 · Cited by 62
Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters
Furuhashi, M., Hiramitsu, S., Mita, T., Omori, A., Fuseya, T., Ishimura, S., Watanabe, Y. S., Hoshina, K., Matsumoto, M., Tanaka, M., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0177-8 · Cited by 58
Self-citationFuruhashi, M., Hiramitsu, S., Mita, T., Fuseya, T., Ishimura, S., Omori, A., Matsumoto, M., Watanabe, Y. S., Hoshina, K., Tanaka, M., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m059469 · Cited by 58
Self-citationAdipocyte Fatty Acid‐binding Protein as a Determinant of Insulin Sensitivity in Morbid‐obese Women
Simón, I., Escoté, X., Vilarrasa, N., Gómez, J. M., Fernández‐Real, J. M., Megía, A., Gutiérrez, C., Gallart, L., Noguera, C. M., & Vendrell, J. J. (2009) · Obesity · doi:10.1038/oby.2008.665 · Cited by 56
A Critical Role of Fatty Acid Binding Protein 4 and 5 (FABP4/5) in the Systemic Response to Fasting
Syamsunarno, M. R. A. A., Iso, T., Hanaoka, H., Yamaguchi, A., Obokata, M., Koitabashi, N., Goto, K., Hishiki, T., Nagahata, Y., Matsui, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079386 · Cited by 56
Yang, R. S., Castriota, G. A., Chen, Y., Cleary, M. A., Ellsworth, K. P., Shin, M. K., Tran, J.-L., Vogt, T., Wu, M. S., Xu, S., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.128 · Cited by 55
Furuhashi, M., Ogura, M., Matsumoto, M., Yuda, S., Muranaka, A., Kawamukai, M., Omori, A., Tanaka, M., Moniwa, N., Ohnishi, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00177-w · Cited by 55
Self-citationHuang, M., Narita, S., Inoue, T., Koizumi, A., Saito, M., Tsuruta, H., Numakura, K., Satoh, S., Nanjo, H., Sasaki, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22908 · Cited by 55
Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015)
Wang, Y., Liu, C., & Zhu, H. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1182500 · Cited by 54
Furuhashi, M., Mita, T., Moniwa, N., Hoshina, K., Ishimura, S., Fuseya, T., Watanabe, Y. S., Yoshida, H., Shimamoto, K., & Miura, T. (2015) · Hypertension Research · doi:10.1038/hr.2015.2 · Cited by 52
Self-citationAdipocyte fatty acid-binding protein is released from adipocytes by a non-conventional mechanism
Kralisch, S., Ebert, T., Lössner, U., Jeßnitzer, B., Stümvoll, M., & Faßhauer, M. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.232 · Cited by 52
Interaction of Adipocyte Fatty Acid-binding Protein (AFABP) and JAK2
Thompson, B. R., Mazurkiewicz-Muñoz, A. M., Suttles, J., Carter‐Su, C., & Bernlohr, D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900075200 · Cited by 52
ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists
Feingold, K. R., Kazemi, M. R., Magra, A. L., McDonald, C. M., Chui, L. G., Shigenaga, J. K., Patzek, S. M., Chan, Z. W., Londos, C., & Grünfeld, C. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.042 · Cited by 52
Tanaka, M., Furuhashi, M., Okazaki, Y., Mita, T., Fuseya, T., Ohno, K., Ishimura, S., Yoshida, H., & Miura, T. (2015) · Nephron Clinical Practice · doi:10.1159/000368412 · Cited by 52
Self-citationHu, W., & Qiao, J. (2011) · Endocrine · doi:10.1007/s12020-011-9495-9 · Cited by 51
Cataltepe, O. I., Arıkan, M., Ghelfi, E., Karaaslan, Ç., Özsürekçi, Y., Dresser, K., Li, Y., Smith, T. W., & Çataltepe, S. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01237.x · Cited by 50
Yeung, D. C. Y., Wang, Y., Xu, A., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn295 · Cited by 50
Syamsunarno, M. R. A. A., Iso, T., Yamaguchi, A., Hanaoka, H., Putri, M., Obokata, M., Sunaga, H., Koitabashi, N., Matsui, H., Maeda, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090825 · Cited by 50
Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
Furuhashi, M., Matsumoto, M., Murase, T., Nakamura, T., Higashiura, Y., Koyama, M., Tanaka, M., Moniwa, N., Ohnishi, H., Saitoh, S., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12982 · Cited by 49
Self-citationBiochemical and biophysical analysis of the intracellular lipid binding proteins of adipocytes
Simpson, M. A., LiCata, V. J., Coe, N. R., & Bernlohr, D. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4929-1_4 · Cited by 47
Numaguchi, R., Furuhashi, M., Matsumoto, M., Sato, H., Yanase, Y., Kuroda, Y., Harada, R., Ito, T., Higashiura, Y., Koyama, M., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011147 · Cited by 47
Self-citationOkazaki, Y., Furuhashi, M., Tanaka, M., Mita, T., Fuseya, T., Ishimura, S., Watanabe, Y. S., Hoshina, K., Akasaka, H., Ohnishi, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115429 · Cited by 45
Self-citationFuruhashi, M., Yuda, S., Muranaka, A., Kawamukai, M., Matsumoto, M., Tanaka, M., Moniwa, N., Ohnishi, H., Saitoh, S., Shimamoto, K., et al. (2018) · Circulation Journal · doi:10.1253/circj.cj-17-1295 · Cited by 45
Self-citationSmith, A. J., Sanders, M. A., Juhlmann, B. E., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806732200 · Cited by 44
Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells
Bosquet, A., Guaita‐Esteruelas, S., Saavedra-García, P., Rodríguez‐Calvo, R., Heras, M., Girona, J., & Masana, L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.04.012 · Cited by 44
Lee, J., Britton, K. A., Pedley, A., Massaro, J. M., Speliotes, E. K., Murabito, J. M., Hoffmann, U., Ingram, C., Keaney, J. F., Vasan, R. S., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002936 · Cited by 43
New insights into circulating FABP4: Interaction with cytokeratin 1 on endothelial cell membranes
Saavedra-García, P., Girona, J., Bosquet, A., Guaita, S., Canela-Canela, N., Aragonès, G., Heras, M., & Masana, L. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.002 · Cited by 39
Yamamoto, T., Furuhashi, M., Sugaya, T., Oikawa, T., Matsumoto, M., Funahashi, Y., Matsukawa, Y., Gotoh, M., & Miura, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167825 · Cited by 38
Self-citationMiao, X., Wang, Y., Wang, W., Lv, X., Wang, M., & Yin, H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.017 · Cited by 37
Gorbenko, O., Panayotou, G., Zhyvoloup, A., Volkova, D., Gout, I. T., & Filonenko, V. V. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0312-1 · Cited by 36
Jin, J., Zhang, Z., Zhang, S., Chen, X., Chen, Z., Hu, P., Wang, J., & Xie, C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.005 · Cited by 36
Shrestha, S., Sunaga, H., Hanaoka, H., Yamaguchi, A., Kuwahara, S., Umbarawan, Y., Nakajima, K., Machida, T., Murakami, M., Saito, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34902-w · Cited by 36
Walenna, N. F., Kurihara, Y., Chou, B., Ishii, K., Soejima, T., Itoh, R., Shimizu, A., Ichinohe, T., & Hiromatsu, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.005 · Cited by 34
Charles, K. N., Li, M., Engin, F., Arruda, A. P., Inouye, K., & Hotamışlıgil, G. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.051 · Cited by 32
Obokata, M., Iso, T., Ohyama, Y., Sunaga, H., Kawaguchi, T., Matsui, H., Iizuka, T., Fukuda, N., Takamatsu, H., Koitabashi, N., et al. (2016) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872616683635 · Cited by 31
Hwang, H., Moon, P., Lee, J., Kim, J., Lee, W., Ryu, S. H., & Baek, M. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0026-6 · Cited by 30
Nourani, M. R., Owada, Y., Kitanaka, N., Sakagami, H., Hoshi, H., Iwasa, H., Spener, F., & Kondo, H. (2006) · The Histochemical Journal · doi:10.1007/s10735-006-9024-y · Cited by 29
Furuhashi, M., Omori, A., Matsumoto, M., Kataoka, Y., Tanaka, M., Moniwa, N., Ohnishi, H., Yoshida, H., Saitoh, S., Shimamoto, K., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.04.037 · Cited by 29
Self-citationHa, M. K., Cho, J. S., Baik, O., Lee, D. W., Koo, H., & Chung, K. Y. (2006) · PROTEOMICS · doi:10.1002/pmic.200500395 · Cited by 28
Fatty Acid Binding Protein 4 Deficiency Protects against Oxygen-Induced Retinopathy in Mice
Saint‐Geniez, M., Ghelfi, E., Liang, X., Yu, D. C. W., Spencer, C., Abend, S., Hotamışlıgil, G. S., & Çataltepe, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096253 · Cited by 26
Iso, T., Sunaga, H., Matsui, H., Kasama, S., Oshima, N., Haruyama, H., Furukawa, N., Nakajima, K., Machida, T., Murakami, M., et al. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.05.021 · Cited by 25
Association of androgen with gender difference in serum adipocyte fatty acid binding protein levels
Hu, X., Ma, X., Pan, X., Luo, Y., Xu, Y., Xiong, Q., Bao, Y., & Jia, W. (2016) · Scientific Reports · doi:10.1038/srep27762 · Cited by 24
Furuhashi, M., Matsumoto, M., Hiramitsu, S., Omori, A., Tanaka, M., Moniwa, N., Yoshida, H., Ishii, J., & Miura, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154482 · Cited by 23
Self-citationCha, Y. J., Kim, H. M., & Koo, J. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010232 · Cited by 20
Furuhashi, M., Mori, K., Tanaka, M., Maeda, T., Matsumoto, M., Murase, T., Nakamura, T., Koyama, M., Moniwa, N., Ohnishi, H., et al. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0127 · Cited by 19
Self-citationColeman, S. L., Park, Y., & Lee, J. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0140-9 · Cited by 18
Effects of intermittent hypoxia on A-/E-FABP expression in human aortic endothelial cells
Han, Q., Yeung, S. C., Ip, M., & Mak, J. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.04.027 · Cited by 17
Induction of gene encoding FABP4 in Pten‐null keratinocytes
Tsuda, M., Inoue-Narita, T., Suzuki, A., Itami, S., Blumenberg, M., & Manabe, M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.03.030 · Cited by 17
Elie, A. G. I. M., Bloksgaard, M., Sun, W. Y., Yang, K., Man, A. W. C., Xu, A., Irmukhamedov, A., Riber, L. P., Wang, Y., & Mey, J. G. R. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206802 · Cited by 11
Wang, Q., Shi, G., Teng, Y., Li, X., Xie, J., Shen, Q., Zhang, C., Ni, S., & Tang, Z. (2017) · Journal of Inflammation · doi:10.1186/s12950-017-0155-6 · Cited by 10
Miehle, K., Ebert, T., Kralisch, S., Hoffmann, A., Kratzsch, J., Schlögl, H., Stümvoll, M., & Faßhauer, M. (2017) · Cytokine · doi:10.1016/j.cyto.2017.01.006 · Cited by 7
Cited by
New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity
Furuhashi, M. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00378.2020 · Cited by 361
Self-citationCalì, C., Cantando, I., Veloz Castillo, M. F., Gonzalez, L., & Bezzi, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168922 · Cited by 66
Metadata
- Authors
- Furuhashi, M.
- Venue
- Journal of Atherosclerosis and Thrombosis
- Publisher
- Japan Atherosclerosis Society
- Published
- 2019-03-01
- Volume
- 26
- Issue
- 3
- Pages
- 216-232
- ISSN
- 1340-3478 (ISSN-L)
- 1880-3873
- OpenAlex
- W2914390923
- Cited by
- 319
- References
- 160
- FWCI
- 21.53
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.